Valuation (55%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 35.84 | N/A |
| PEG Ratio (TTM) | 69.89 | N/A |
| P/S Ratio (TTM) | 3.98 | N/A |
| P/B Ratio (TTM) | 4.84 | N/A |
| P/FCF Ratio (TTM) | 29.98 | N/A |
| Price to 5YR AVG Earnings Ratio | 47.41 | N/A |
| Price to 5YR AVG FCF Ratio | 38.83 | N/A |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 7.72% | N/A |
| ROE (TTM) | 14.30% | N/A |
| Net Profit Margin (TTM) | 11.12% | N/A |
| ROIC 5YR AVG | 17.06% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 1.50% | 13.26% | 15.66% |
| Revenue | 2.82% | 8.39% | 9.21% |
| Net Income | 1.64% | 14.82% | 16.87% |
| Cash Flow | 18.64% | 41.63% | 29.87% |
Health (81%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.29 | N/A |
| Quick Ratio (TTM) | 1.46 | N/A |
| D/E Ratio (TTM) | 0.38 | N/A |
| Interest Coverage (TTM) | 10.53 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 6.03 | N/A |
| LTL to 5YR AVG FCF | 1.20 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.09% | N/A |